Lupin Launches Azilsartan Medoxomil Tablets in the United States

MUMBAI, India and Naples, Fla., June 17, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of Azilsartan Medoxomil Tablets, 40mg and 80mg in the United States following the...